Tokyo-based TIME TRAVELER screened more than 140 edible plant and algae species and identified parsley-derived exosomes as functional analogues to human-derived exosomes, which carry significant sourcing and regulatory constraints. In aged mice, the exosomes reduced inflammatory markers and preserved grip strength, and a 40-person pilot reported lower inflammation alongside improved sleep consistency and daytime energy. The team is one of ten finalists advancing in the $101 million XPRIZE Healthspan competition.
Key Points
- Parsley exosomes outperformed 140+ screened plants in human cell assays
- Aged mice retained muscle strength and showed reduced inflammatory markers
- 40-person pilot showed lower inflammation, better sleep and energy
Longevity Analysis
Chronic low-grade inflammation sits upstream of muscle loss, cognitive decline and impaired tissue repair, making an orally available, plant-sourced signaling vehicle an unusually practical intervention point. The shift away from human and animal tissue removes a layer of contamination and regulatory risk that has constrained the exosome field, particularly in unregulated cosmetic channels. The pending XPRIZE trial — measuring walking, leg strength, cognitive performance and inflammatory blood markers — will determine whether early biomarker movement translates into functional capacity that holds over time.
Original published by Longevity.Technology, by Kyle Umipig.